Innovac Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Innovac Therapeutics's estimated annual revenue is currently $2M per year.
- Innovac Therapeutics's estimated revenue per employee is $77,500
- Innovac Therapeutics's total funding is $18M.
Employee Data
- Innovac Therapeutics has 26 Employees.
- Innovac Therapeutics grew their employee count by 63% last year.
Innovac Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder, Chief Technical Officer | Reveal Email/Phone |
2 | VP, Biology | Reveal Email/Phone |
3 | VP, Immunology | Reveal Email/Phone |
4 | Head People Strategy | Reveal Email/Phone |
5 | Head Regulatory & Quality | Reveal Email/Phone |
6 | LNP Formulation & Analytics | Reveal Email/Phone |
7 | Scientist II | Reveal Email/Phone |
8 | Associate Scientist | Reveal Email/Phone |
9 | Senior Scientist, Lipid Chemistry | Reveal Email/Phone |
10 | Scientist II | Reveal Email/Phone |
Innovac Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Innovac Therapeutics?
Innovac Therapeutics is a biotechnology company dedicated to developing innovative vaccines for patients with unmet medical needs, using our proprietary RNA technology platforms and manufacturing capabilities.
keywords:N/A$18M
Total Funding
26
Number of Employees
$2M
Revenue (est)
63%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.5M | 26 | -40% | N/A |
#2 | $10.4M | 26 | -47% | $124.9M |
#3 | $2.5M | 26 | -28% | N/A |
#4 | $6.5M | 26 | -54% | N/A |
#5 | $2M | 26 | 0% | $226.9M |